Patient Controlled Analgesia Pumps Market Expected to Reach $407.9 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Patient Controlled Analgesia Pumps Market," The patient controlled analgesia pumps market size was valued at $277.67 million in 2021, and is estimated to reach $407.9 million by 2031, growing at a CAGR of 3.9% from 2022 to 2031.

In a patient-controlled analgesia system, the patient uses a programmable pump to self-administer painkillers. Patients who have trouble taking an oral drug patient-controlled analgesia pumps are used. A patient-controlled analgesia pump is a computerized pump that continuously administers a small amount of medication through a medication syringe.  

By simply pressing the push button, PCA pumps enable patients to self-administer large dosages of drugs into the vein. It also helps with pain management after surgery to hasten recovery. Similarly, these pumps assist in minimizing or eliminating the need for intramuscular injections. When compared to other forms of analgesic, it also provides patients with less anxiety, better analgesic effects, and significant improvements in pulmonary problems. Therefore, a number of benefits connected to PCA pumps include increased patient satisfaction, enhanced pain relief, and fewer surgical problems, boosting the market growth. 

Pain is caused due various diseases and surgeries, leading to increased cases of hospitalization. In certain cases of extreme pain, patients are unable to take drugs orally. Thus, to overcome this condition injectable formulations are administered through infusion pumps to relieve pain. Patient-controlled analgesia (PCA) pumps are specifically designed for pain medication therapies and have wide applications in pain management. Increase in incidence of chronic pain and introduction of novel medicines and biologics for pain management drives the patient controlled analgesia pumps market growth.  

Factors that drive growth of global patient controlled analgesia pumps market include increase in demand for patient controlled analgesic pumps in developed countries such as the U.S. Rise in number of surgeries such as orthopedics surgery, oncology surgery, and others requires the anesthesia pump to manage the pain this has led to drive the market growth. Major players are also supporting the development and distribution of patient-controlled analgesia pumps further supports the market growth. 

Rise in technological advancements in analgesic pumps & digitilization are the patient controlled analgesia pumps market trends. Companies are working to provide multidirectional interoperability, secure patient and instrument data, and integrate complete medication libraries into pumps (better electronic health record management). These are expected to enhance the administration of medication in various care settings. 

For instance, Volumed µVP7000 and Syramed µSP6000 are products of Arcomed AG company, which has various features such as convenient patient bolus button, preset programs for enhanced safety and convenience and password and locking mechanism. Furthermore, Alaris PCA module a product of Becton, Dickinson and Company has the features such as less adverse drug events, large volume pump (LVP), and syringe pump on a single hardware platform. Such advanced features in analgesic pumps surges their demand and contributes towards the market growth.

Moreover, increase in hospital patients and the rise in incidences of cancer, orthopedics problem, and all of which are associated with chronic pain. For instance, according to the American Cancer Society, in 2022, around 1.9 million new cancer cases were expected to occur in the U.S. Thus, rise in prevalence of cancer cases led to increase the demand for patient controlled analgesic pumps and further supports the market growth. 

Depending on type, the market is bifurcated into electronic & wireless and mechanical. The electronic & wireless segment exhibited largest patient controlled analgesia pumps market share 2021, and is expected to remain dominant during the forecast period, owing to advantages provided by electronic patient controlled analgesic pumps such as reusable, adaptable, flexible, and convenient for patient.  

On the basis of application, the market is segmented into oncology & hematology, gastroenterology, and others. The oncology & hematology segment exhibited largest growth in 2021, owing to rise in prevalence of cancer disease. On the basis of end user, the market is classified into hospitals, ambulatory surgical centers, and others. The others segment dominated the market in 2021, and is expected to remain dominant during the forecast period, owing to availability of patient controlled analgesic pumps and advanced facilities in home care settings and in cancer centers.  

Region wise, North America had the largest market share in 2021, and is expected to maintain its lead during the forecast period, owing to increase in demand for patient controlled analgesic pumps due to rise in cases of chronic pain cases in this region. However, Asia-Pacific is expected to witness highest growth during the forecast period, owing to rise in investments in manufacturing of high-quality patient controlled analgesic pumps and rise in healthcare infrastructure. 

Key findings of the study  

• By type, the electronic & wireless, segment was highest contributor to the patient controlled analgesia pumps industry in 2021.  
• On the basis of application, the oncology & hematology segment dominated the market in 2021.  
• By end user, the others segment dominated the market in 2021, and is expected to grow at a CAGR during the forecast period.  
• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.